Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thiamazol Effect on Melasma in Hyperthyroid Patients
NCT04346901Phase 1Completed
- Start
- Aug 2019
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of methimazole in hyperthyroidism. Primary endpoint: modified Melasma Area and Severity Index at 3 months. Started Aug 2019; status: completed.
02
Drugs
methimazole
03
Conditions
hyperthyroidism
Beyond the preview
Go deeper on NCT04346901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04346901.